medline.ch Urologie-Nephrologie Tumoren BPH

	Open vs. robotic prostatectomy using Versius(Â®): perioperative, oncologic & learning curve outcomes. J Robot Surg Hammadeh BM, Abuhamad M, Ghanem R. PMID: 42579233 [PubMed - indexed for MEDLINE]
	Single-port vs. multi-port robotic radical prostatectomy: an umbrella review of meta-analyses. J Robot Surg Kumar L, Pal AK, Yuan Y, Ghorai RP, Kishore TA, Khairnar MR, Burton E, Sidana A, Saini S. PMID: 42579231 [PubMed - indexed for MEDLINE]
	Big Data Analytics in Urologic Oncology: A Comprehensive Review of Large-scale Database Research and Clinical Applications. Curr Urol Rep Bourgi A, Rusch E, Bigot P, Bruyère F. PMID: 42579222 [PubMed - indexed for MEDLINE]
	Frailty and comorbidity surpass probable sarcopenia in predicting survival of mCRPC patients treated with first-line ARPIs: a comprehensive geriatric analysis. World J Urol Cheng YL, Kao CC, Meng E, Cha TL, Tsai YT, Tsao CW, Yang MH. PMID: 42578984 [PubMed - indexed for MEDLINE]
	CTCAE-Guided Management of Cytotoxic Chemotherapy Toxicity in Uro-Oncology: A Contemporary Narrative Review. Acta Medica (Hradec Kralove) Tranová MN, Izmaylov O, Princlová H, Navrátil P. PMID: 42578385 [PubMed - indexed for MEDLINE]
	De-escalation surgery for localized prostate cancer: rationale and future direction of precision prostatectomy. Curr Opin Urol Franke J, Rogers CG, Zuluaga L, Badani K, Menon M. PMID: 42578299 [PubMed - indexed for MEDLINE]
	Engineering Multimodal Nanomaterials for Prostate Cancer Theranostics: Design Principles, Recent Advances, and Translational Challenges. Int J Nanomedicine Wang J, Zhang Z, Li H, Teng Y, Chen B, Zuo J, Li X, Zhan P, Fu S, Xu Y, Wen L, Wang B, Fu Y, Qin K, Chen W, Huang Y, Shi Y, Chen J, Zhao J. PMID: 42577912 [PubMed - indexed for MEDLINE]
	Deep learning model based on CT images to predict Ki-67 expression in renal carcinoma. Oncol Lett Shen D, Li H, Shi B, Ma T, Zhou B, Gao C, Liu Y, Cui Z. PMID: 42577766 [PubMed]
	First-line immune checkpoint inhibitor plus anti-angiogenic therapy for advanced renal cell carcinoma: a meta-analysis of randomized controlled trials. Front Pharmacol Liu Z, Jiang Y, Zhang Z, Liu J. PMID: 42577666 [PubMed]
	Effects of self-management interventions on self-care ability and quality of life in patients with urinary ostomy after bladder cancer: a systematic review and meta-analysis. Front Oncol Tian J, Li L, Xu L, Liu L. PMID: 42577118 [PubMed]
	A four-miRNA serum panel as a diagnostic biomarker for prostate cancer: an exploratory and validation study. Front Oncol Yang Z, Lai Z, Xie J, Chen S, Ge Z, Lai Y, Li H. PMID: 42577108 [PubMed]
	Triplet Therapy (Androgen Deprivation Therapy + Darolutamide + Biweekly Docetaxel) for High-risk Metastatic Castration-sensitive Prostate Cancer (TRIC Study): A Study Protocol for Open-labelled Single-Arm Phase II Clinical Trial. JMA J Iwamoto H, Hori T, Inaba T, Nakagawa R, Kamijima T, Kano H, Makino T, Naito R, Yaegashi H, Nohara T, Shigehara K, Izumi K, Mizokami A. PMID: 42577021 [PubMed]
	Metastasis-directed therapy in oligoprogressive prostate cancer: current evidence and future directions. Ann Palliat Med Wang JH, Huang D, Amoateng EJ, Tipirneni A, Zhang H, Bylund K, Cummings M, Tran PT, Deek MP, Sutera PA. PMID: 42576472 [PubMed - indexed for MEDLINE]
	Clinical Outcomes of Single-Dose Flomoxef Prophylaxis for Transrectal Prostate Biopsy: A Single-Center Study of 834 Cases. Int J Urol Sugihara N, Sawada T, Arai H, Nishida K, Ohnishi T, Watanabe R, Nishimura K, Fukumoto T, Miura N, Miyauchi Y, Saika T. PMID: 42576438 [PubMed - indexed for MEDLINE]
	Validation of the NCCN Subclassification for Intermediate-Risk Prostate Cancer in a Japanese Radical Prostatectomy Cohort: Results From the MICAN Study. Int J Urol Oono T, Terashita M, Mori S, Oka A, Matsuzaki S, Yano A, Matsumura M, Ninomiya I, Shinomori K, Ogawa T, Onishi T, Shirato A, Watanabe Y, Hashine K, Yamashita N, Watanabe R, Miura N, Saika T. PMID: 42576432 [PubMed - indexed for MEDLINE]
	Natural History, Tumor Growth Kinetics, and Renal Functional Outcomes of Sporadic Bilateral Multifocal Papillary Renal Cell Carcinoma: A 25-yr Prospective Cohort Study. Eur Urol Oncol Fu H, Blachman-Braun R, Loebach L, Owens-Walton J, Millan B, Michael P, Patel M, Vocke CD, Ricketts CJ, Schmidt LS, Gautam R, Merino MJ, Gurram S, Marston Linehan W, Ball MW. PMID: 42575757 [PubMed - as supplied by publisher]
	Exploring the Putative Role of EGFR in Prostate Cancer: Interactions with Androgen and Estrogen Receptors. J Steroid Biochem Mol Biol Gonçalves GM, Souza DS, Costa C, Oliveira M, Porto CS, Vicente CM. PMID: 42575475 [PubMed - as supplied by publisher]
	Building a Natural Language Processing Augmented Information Support System to Enhance Supportive Care for Patients With Prostate Cancer and Families: User-Centered, Iterative Approach. J Med Internet Res Song L, Wang X, Yu F, Zuo D, Ranzinger LH, Liss M, Tan HJ. PMID: 42574684 [PubMed - indexed for MEDLINE]
	Evaluation of Stimulated Raman Histology as a Novel Method for Pathologic Examination of Urothelial Carcinoma With Unprocessed, Fresh Bladder Cancer Tissue. Technol Cancer Res Treat Maisch P, Mühlberger M, Beck A, Schreen W, Mannas MP, Horsch C, Bolenz C. PMID: 42574263 [PubMed - indexed for MEDLINE]
	Disability Status and Prostate Cancer Screening Among US Men Aged 55 to 69 Years. JAMA Netw Open Nolazco JI, Iezzoni LI, Chen EC, Park ER, Wang W, Leapman MS, Alkhatib KY, Teoh JYC, Cole AP, Mossanen M, Lay AH, Bartels SJ, Kibel AS, Feldman AS, Chang SL. PMID: 42574016 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 190394

Seite 1 von 9520



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung